Safety, anti-tumour activity, and biomarker results of the HER2-targeted bispecific antibody ZW25 in HER2-expressing solid tumours
Meric-Bernstam, F., Hanna, D., Beeram, M., Lee, K.-W., Kang, Y.-K., Chaves, J., Lee, J., Goodwin, R., Vaklavas, C., Oh, D.-Y., Rha, S.Y., Elimova, E., Mayordomo, J., Ferrario, C., Cobleigh, M.A., Fortenberry, A., Rowse, G., Gray, T., Lai, R., Hamilton, E.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
453PD - Safety, anti-tumour activity, and biomarker results of the HER2-targeted bispecific antibody ZW25 in HER2-expressing solid tumours
Meric-Bernstam, F., Hanna, D., Beeram, M., Lee, K.-W., Kang, Y.-K., Chaves, J., Lee, J., Goodwin, R., Vaklavas, C., Oh, D.-Y., Rha, S.Y., Elimova, E., Mayordomo, J., Ferrario, C., Cobleigh, M.A., Fortenberry, A., Rowse, G., Gray, T., Lai, R., Hamilton, E.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
SU11248 (sunitinib malate) therapy in patients with refractory metastatic breast cancer: preliminary safety and efficacy results from a phase II study
Miller, K.D., Burstein, H.J., Elias, A.D., Rugo, H.S., Cobleigh, M.A., Wolff, A.C., Eisenberg, P.D., Collier, M., Adams, B.J., Baum, C.M.
Published in European journal of cancer supplements (01.03.2006)
Published in European journal of cancer supplements (01.03.2006)
Get full text
Journal Article
First-line, single-agent Herceptin® (trastuzumab) in metastatic breast cancer
Vogel, C., Cobleigh, M.A., Tripathy, D., Gutheil, J.C., Harris, L.N., Fehrenbacher, L., Slamon, D.J., Murphy, M., Novotny, W.F., Burchmore, M., Shak, S., Stewart, S.J.
Published in European journal of cancer (1990) (01.01.2001)
Published in European journal of cancer (1990) (01.01.2001)
Get full text
Journal Article